[go: up one dir, main page]

BRPI0412835A - processo para preparação de uma solução de alfa-1-antitripsina - Google Patents

processo para preparação de uma solução de alfa-1-antitripsina

Info

Publication number
BRPI0412835A
BRPI0412835A BRPI0412835-4A BRPI0412835A BRPI0412835A BR PI0412835 A BRPI0412835 A BR PI0412835A BR PI0412835 A BRPI0412835 A BR PI0412835A BR PI0412835 A BRPI0412835 A BR PI0412835A
Authority
BR
Brazil
Prior art keywords
a1at
preparing
alpha
solution
antitrypsin solution
Prior art date
Application number
BRPI0412835-4A
Other languages
English (en)
Inventor
Petra Schulz
Juergen R Misch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of BRPI0412835A publication Critical patent/BRPI0412835A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE UMA SOLUçãO DE ALFA-1-ANTITRIPSINA". A presente invenção refere-se a um processo para preparação da A1AT a partir de soluções contendo A1AT, compreendendo as seguintes etapas: (a) exposição da uma solução contendo A1AT à cromatografia de troca iónica; (b) adição de detergentes e opcionalmente um solvente para inativação do envelope lipídico dos vírus; (c) seguida de um aumento da concentração de sal para extração dos detergentes por proceder o 'salting-out'. A1AT possuindo uma pureza de > 90% com uma atividade de <242> 0,8 PEU/mg na sua forma ativa.
BRPI0412835-4A 2003-08-12 2004-08-12 processo para preparação de uma solução de alfa-1-antitripsina BRPI0412835A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
BRPI0412835A true BRPI0412835A (pt) 2006-09-26

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412835-4A BRPI0412835A (pt) 2003-08-12 2004-08-12 processo para preparação de uma solução de alfa-1-antitripsina

Country Status (22)

Country Link
US (1) US20060194300A1 (pt)
EP (1) EP1654284B1 (pt)
JP (1) JP4668904B2 (pt)
KR (1) KR20060070543A (pt)
CN (1) CN1867582B (pt)
AT (1) ATE428730T1 (pt)
AU (1) AU2004262578B2 (pt)
BR (1) BRPI0412835A (pt)
CA (1) CA2534900A1 (pt)
DE (1) DE602004020632D1 (pt)
DK (1) DK1654284T3 (pt)
ES (1) ES2324168T3 (pt)
IL (1) IL172868A0 (pt)
NO (1) NO20060109L (pt)
PL (1) PL1654284T3 (pt)
PT (1) PT1654284E (pt)
RS (1) RS20060077A (pt)
RU (1) RU2370500C2 (pt)
SI (1) SI1654284T1 (pt)
UA (1) UA86775C2 (pt)
WO (1) WO2005014648A1 (pt)
ZA (1) ZA200601206B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE391730T1 (de) * 2003-09-22 2008-04-15 Kamada Ltd Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
US20110002909A1 (en) * 2007-11-02 2011-01-06 Vikram Arora Method, composition, and article of manufacture for providing alpha-1 antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
MY179524A (en) 2015-06-26 2020-11-10 Ferring Bv Methods of purification and/or viral inactivation
KR20180101583A (ko) * 2016-02-03 2018-09-12 플라즈마 테크놀로지스, 엘엘씨 혈액 기반 물질로부터 단백질을 추출하기 위한 방법(methods for extracting proteins from a blood-based material)
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
ES2053606T3 (es) * 1987-04-27 1994-08-01 Miles Inc Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
EP0871671A1 (en) * 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
RS20060077A (sr) 2008-08-07
WO2005014648A1 (en) 2005-02-17
ZA200601206B (en) 2007-05-30
US20060194300A1 (en) 2006-08-31
CN1867582A (zh) 2006-11-22
CA2534900A1 (en) 2005-02-17
JP4668904B2 (ja) 2011-04-13
DK1654284T3 (da) 2009-07-20
RU2370500C2 (ru) 2009-10-20
UA86775C2 (ru) 2009-05-25
SI1654284T1 (sl) 2009-10-31
RU2006107533A (ru) 2006-07-27
NO20060109L (no) 2006-02-15
AU2004262578B2 (en) 2010-05-06
JP2007523883A (ja) 2007-08-23
KR20060070543A (ko) 2006-06-23
CN1867582B (zh) 2010-06-16
PL1654284T3 (pl) 2009-09-30
AU2004262578A1 (en) 2005-02-17
ES2324168T3 (es) 2009-07-31
DE602004020632D1 (de) 2009-05-28
EP1654284A1 (en) 2006-05-10
PT1654284E (pt) 2009-07-06
EP1654284B1 (en) 2009-04-15
IL172868A0 (en) 2006-06-11
ATE428730T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
BRPI0412835A (pt) processo para preparação de uma solução de alfa-1-antitripsina
BR0112538A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos
BR0214386A (pt) Método para identificação de enzimas de objetivação a tumor
BR0111457A (pt) Derivados de acilfeniluréia, processos para a sua preparação e sua aplicação como medicamentos
BRPI0508854A (pt) sais farmacêuticos de ácido-3-o-(3&#39;,3&#39;-dimetilsuccinil) betulìnico
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
BR0213539A (pt) Compostos, processo para a preparação de compostos, composições farmacêuticas que compreendem um composto método para o tratamento e/ou profilaxia de enfermidades que estão associadas com dpp iv e utilização desses compostos
BR0212158A (pt) Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar
BR0010080A (pt) Inibidores de renina
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BR9912240A (pt) Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos
BR0313831A (pt) Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
BRPI0513379A (pt) derivados de sulfonamida
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
Fenton et al. Biogenesis of the mitochondrial enzyme methylmalonyl-CoA mutase. Synthesis and processing of a precursor in a cell-free system and in cultured cells.
WO2005063219A3 (en) Ibuprofen-containing soft gelatin capsules
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
BRPI9910445B8 (pt) preparação farmacêutica na forma de comprimido, bem como seu processo de produção
BRPI0411800A (pt) candidatos a fármacos e métodos para sua preparação
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
BR9915019A (pt) Derivados de propanolamina ligados com ácido biliar para o tratamento de distúrbios do metabolismo de lipìdeos
AR035808A1 (es) Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
HUP0102075A2 (hu) Stabil mitoxantron-oldatok, eljárás az előállításukra
Zhong et al. An antimicrobial peptide as a potential therapy for bacterial pneumonia that alleviates antimicrobial resistance
BRPI0513935A (pt) formulações de compostos de 2-amina-1,3-propanodiol

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]